| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ACTB
|
actin, beta
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
AFP
|
alpha-fetoprotein
|
|
AGR3
|
anterior gradient 3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALB
|
albumin
|
|
APC
|
adenomatous polyposis coli
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARSA
|
arylsulfatase A
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
ATF2
|
activating transcription factor 2
|
|
AZIN2
|
antizyme inhibitor 2
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BECN1
|
beclin 1, autophagy related
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C17ORF97
|
chromosome 17 open reading frame 97
|
|
CAPNS1
|
calpain, small subunit 1
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCHCR1
|
coiled-coil alpha-helical rod protein 1
|
|
CCND1
|
cyclin D1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD68
|
CD68 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTAG1A
|
cancer/testis antigen 1A
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL4A
|
cullin 4A
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNER
|
delta/notch-like EGF repeat containing
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRB
|
estrogen-related receptor beta
|
|
EYA4
|
EYA transcriptional coactivator and phosphatase 4
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FBLN1
|
fibulin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGBP
|
Fc fragment of IgG binding protein
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXM1
|
forkhead box M1
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FTO
|
fat mass and obesity associated
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GADL1
|
glutamate decarboxylase-like 1
|
|
GINS2
|
GINS complex subunit 2 (Psf2 homolog)
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLS
|
glutaminase
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNAS
|
GNAS complex locus
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GPC3
|
glypican 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC8
|
histone deacetylase 8
|
|
HDAC9
|
histone deacetylase 9
|
|
HHLA2
|
HERV-H LTR-associating 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HOMER1
|
homer scaffolding protein 1
|
|
HOXB7
|
homeobox B7
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IL1B
|
interleukin 1, beta
|
|
IMP3
|
IMP3, U3 small nucleolar ribonucleoprotein
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KDR
|
kinase insert domain receptor
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LDHA
|
lactate dehydrogenase A
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MFAP5
|
microfibrillar associated protein 5
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MMRN1
|
multimerin 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC13
|
mucin 13, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NEUROG1
|
neurogenin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NOTCH1
|
notch 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRDC
|
nardilysin convertase
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PBRM1
|
polybromo 1
|
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7
|
|
PCYT1A
|
phosphate cytidylyltransferase 1, choline, alpha
|
|
PDZK1IP1
|
PDZK1 interacting protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PKM
|
pyruvate kinase, muscle
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPA1
|
pyrophosphatase (inorganic) 1
|
|
PPHLN1
|
periphilin 1
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PROM1
|
prominin 1
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSG2
|
pregnancy specific beta-1-glycoprotein 2
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
RAB1A
|
RAB1A, member RAS oncogene family
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBP1
|
retinol binding protein 1, cellular
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RNF2
|
ring finger protein 2
|
|
RNF43
|
ring finger protein 43
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPL41
|
ribosomal protein L41
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A6
|
S100 calcium binding protein A6
|
|
SATB1
|
SATB homeobox 1
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
|
|
SETD2
|
SET domain containing 2
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial)
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAZ
|
tafazzin
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TFDP1
|
transcription factor Dp-1
|
|
TFF1
|
trefoil factor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRIM44
|
tripartite motif containing 44
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2F
|
ubiquitin-conjugating enzyme E2F (putative)
|
|
UBE2M
|
ubiquitin-conjugating enzyme E2M
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
UHRF2
|
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
YAP1
|
Yes-associated protein 1
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
